Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally. The company offers Xywav to treat cataplexy or excessive daytime sleepiness (EDS) with narcolepsy a...
Q2 2026
Aug 4, 2026
Q1 2026
May 5, 2026
FY 2025
Feb 24, 2026
Q4 2025
Q3 2025
Nov 5, 2025
